UROGEN PHARMA - 48 Year Dividend History | URGN

Historical dividend payout and yield for UROGEN PHARMA (URGN) since 1971. The current TTM dividend payout for UROGEN PHARMA (URGN) as of June 24, 2019 is $0.00. The current dividend yield for UROGEN PHARMA as of June 24, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.475B $0.001B
UroGen Pharma Ltd. is a clinical stage biopharmaceutical company. It focused on developing urological pathologies with a focus on uro-oncology. The company's product candidates include MitoGel and VesiGel which are in clinical trial stage. Its platform technologies include: RTGel and Immunotherapy. UroGen Pharma Ltd. is based in Ra'anana, Israel.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $114.125B 12.90
Gilead Sciences (GILD) United States $88.452B 10.74
Bio-Techne Corp (TECH) United States $7.965B 54.34